HFMRX
Price
$24.05
Change
+$0.05 (+0.21%)
Updated
Sep 18 closing price
Net Assets
3.03B
PAMCX
Price
$90.91
Change
-$0.03 (-0.03%)
Updated
Sep 18 closing price
Net Assets
20.82B
Interact to see
Advertisement

HFMRX vs PAMCX

HFMRX vs PAMCX Comparison Chart in %
View a ticker or compare two or three
VS
HFMRX vs. PAMCX commentary
Sep 20, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HFMRX is a Hold and PAMCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PAMCX has more cash in the bank: 20.8B vs. HFMRX (3.03B). HFMRX (0.00) and PAMCX (0.00) have matching dividends . HFMRX was incepted earlier than PAMCX: HFMRX (17 years) vs PAMCX (26 years). HFMRX (1.48) is less costly to investors than PAMCX (1.02). HFMRX is a more actively managed with annual turnover of: 81.00 vs. PAMCX (31.50). HFMRX has a lower initial minimum investment than PAMCX: HFMRX (0) vs PAMCX (2500). PAMCX annual gain was more profitable for investors over the last year : -6.24 vs. HFMRX (-23.21). PAMCX return over 5 years is better than : -26.21 vs. HFMRX (-41.64).
HFMRXPAMCXHFMRX / PAMCX
Total Expense Ratio1.481.02145%
Annual Report Gross Expense Ratio1.481.02145%
Fund Existence17 years26 years-
Gain YTD0.754-0.121-624%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets3.03B20.8B15%
Annual Yield % from dividends0.000.00-
Returns for 1 year-23.21-6.24372%
Returns for 3 years-12.61-2.02626%
Returns for 5 years-41.64-26.21159%
Returns for 10 years-11.6822.29-52%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GGOUX21.680.02
+0.09%
Goldman Sachs Mid Cap Growth R6
FGDDX43.380.04
+0.09%
Fidelity Advisor® Dividend Growth A
JOHIX29.66-0.01
-0.03%
JOHCM International Select Institutional
SIPIX30.42-0.13
-0.43%
SEI Mid-Cap I (SIMT)
BRSUX16.86-0.08
-0.47%
MFS Blended Research Small Cap Eq R4